Discover the patients who need timely treatment for metabolic
dysfunction–associated steatohepatitis (MASH). How will you find
them? And then what will you do?
Credit available for this activity expires: [12/30/26]
Earn Credit / Learning Objectives & Disclosures:
Alarming in immunoglobulin A nephropathy (IgAN): over 40%
present late. Explore latest advancements in management of the most
common cause of primary glomerulonephritis worldwide.
Credit available for this activity expires: 12/23/26
Earn Credit / Learning Objectives & Disclosures: